- Home
- BVS vs ATLC Comparison
BVS vs ATLC Comparison
Compare BVS & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BVS | ATLC |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | 417 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.1M | 726.2M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | BVS | ATLC |
|---|---|---|
| Price | $9.18 | $53.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $14.00 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 388.1K | 57.0K |
| Earning Date | 03-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.43 | $472.00 |
| Revenue Next Year | $6.61 | $7.66 |
| P/E Ratio | $28.06 | ★ $9.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $42.03 |
| 52 Week High | $9.56 | $78.91 |
Technical Indicators
Market Signals| Indicator | BVS | ATLC |
|---|---|---|
| Relative Strength Index (RSI) | 60.47 | 46.37 |
| Support Level | $7.04 | $48.15 |
| Resistance Level | $9.53 | $58.83 |
| Average True Range (ATR) | 0.31 | 3.19 |
| MACD | 0.02 | 0.19 |
| Stochastic Oscillator | 90.04 | 49.08 |
Price Performance
Historical ComparisonAbout BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
About ATLC Atlanticus Holdings Corporation
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.